Vericel Depreciation vs Net Income Analysis

VCEL Stock

USD 47.99 2.34 4.65%

Vericel Corp financial indicator trend analysis is much more than just breaking down Vericel Corp Ord prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vericel Corp Ord is a good investment. Please check the relationship between Vericel Corp Depreciation and its Net Income accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

Depreciation vs Net Income

Depreciation vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vericel Corp Ord Depreciation account and Net Income. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Vericel Corp's Depreciation and Net Income is 0.55. Overlapping area represents the amount of variation of Depreciation that can explain the historical movement of Net Income in the same time period over historical financial statements of Vericel Corp Ord, assuming nothing else is changed. The correlation between historical values of Vericel Corp's Depreciation and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation of Vericel Corp Ord are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Depreciation i.e., Vericel Corp's Depreciation and Net Income go up and down completely randomly.

Correlation Coefficient

0.55

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Depreciation

Depreciation indicates how much of Vericel Corp Ord value has been used up. For tax purposes Vericel Corp can deduct the cost of the tangible assets it purchases as business expenses. However, Vericel Corp Ord must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Vericel Corp Ord financial statement analysis. It represents the amount of money remaining after all of Vericel Corp Ord operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most indicators from Vericel Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vericel Corp Ord current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

At this time, Vericel Corp's Selling General Administrative is quite stable compared to the past year. Enterprise Value is expected to rise to about 1.7 B this year, although the value of Tax Provision will most likely fall to about 331.1 K.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	113.9M	126.8M	142.0M	149.1M
Cost Of Revenue	50.2M	54.6M	61.9M	65.0M

Total Operating Expenses Cost Of Revenue

Vericel Corp fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock Total Equity	Short Term Investments	Common Stock	Inventory	Property Plant Equipment
Total Assets		0.94	0.53	0.94	0.99	0.97	0.23	-0.62	0.92	0.94	0.97	0.98	0.98	0.85	0.9	0.99	0.85	0.95	0.9	0.99	0.88	0.73	0.76	0.92	0.95	0.96
Short Long Term Debt Total	0.94		0.46	0.84	0.89	0.95	0.46	-0.36	0.84	0.89	0.94	0.89	0.9	0.75	0.98	0.94	0.8	0.97	0.87	0.9	0.83	0.58	0.69	0.77	0.86	0.9
Other Current Liab	0.53	0.46		0.75	0.5	0.56	-0.01	-0.25	0.7	0.51	0.54	0.5	0.49	0.24	0.43	0.56	0.84	0.55	0.65	0.5	0.42	0.57	0.37	0.44	0.43	0.41
Total Current Liabilities	0.94	0.84	0.75		0.91	0.93	0.15	-0.62	0.94	0.9	0.93	0.89	0.92	0.75	0.83	0.94	0.94	0.92	0.91	0.91	0.78	0.76	0.64	0.87	0.88	0.89
Total Stockholder Equity	0.99	0.89	0.5	0.91		0.93	0.14	-0.69	0.89	0.91	0.94	0.99	0.98	0.88	0.84	0.98	0.8	0.9	0.85	0.99	0.9	0.76	0.81	0.96	0.95	0.95
Property Plant And Equipment Net	0.97	0.95	0.56	0.93	0.93		0.31	-0.51	0.91	0.95	1.0	0.89	0.94	0.74	0.95	0.96	0.88	0.98	0.94	0.92	0.8	0.66	0.61	0.84	0.88	0.94
Net Debt	0.23	0.46	-0.01	0.15	0.14	0.31		0.35	0.08	0.08	0.31	0.14	0.2	0.11	0.51	0.23	0.22	0.41	0.15	0.16	0.27	-0.3	0.23	-0.01	0.21	0.32
Retained Earnings	-0.62	-0.36	-0.25	-0.62	-0.69	-0.51	0.35		-0.59	-0.55	-0.52	-0.64	-0.7	-0.79	-0.31	-0.62	-0.39	-0.42	-0.44	-0.66	-0.6	-0.64	-0.51	-0.86	-0.61	-0.58
Accounts Payable	0.92	0.84	0.7	0.94	0.89	0.91	0.08	-0.59		0.91	0.91	0.87	0.92	0.72	0.82	0.92	0.91	0.89	0.94	0.89	0.75	0.81	0.6	0.84	0.83	0.81
Cash	0.94	0.89	0.51	0.9	0.91	0.95	0.08	-0.55	0.91		0.95	0.89	0.91	0.74	0.9	0.93	0.84	0.93	0.94	0.91	0.71	0.77	0.54	0.84	0.89	0.89
Non Current Assets Total	0.97	0.94	0.54	0.93	0.94	1.0	0.31	-0.52	0.91	0.95		0.9	0.94	0.75	0.95	0.97	0.88	0.98	0.92	0.93	0.8	0.65	0.63	0.85	0.91	0.96
Cash And Short Term Investments	0.98	0.89	0.5	0.89	0.99	0.89	0.14	-0.64	0.87	0.89	0.9		0.96	0.88	0.82	0.97	0.78	0.88	0.83	1.0	0.91	0.76	0.86	0.94	0.94	0.92
Net Receivables	0.98	0.9	0.49	0.92	0.98	0.94	0.2	-0.7	0.92	0.91	0.94	0.96		0.9	0.87	0.98	0.8	0.92	0.87	0.98	0.89	0.76	0.76	0.95	0.94	0.93
Common Stock Shares Outstanding	0.85	0.75	0.24	0.75	0.88	0.74	0.11	-0.79	0.72	0.74	0.75	0.88	0.9		0.67	0.85	0.53	0.73	0.62	0.9	0.86	0.65	0.8	0.94	0.86	0.82
Non Current Liabilities Total	0.9	0.98	0.43	0.83	0.84	0.95	0.51	-0.31	0.82	0.9	0.95	0.82	0.87	0.67		0.9	0.82	0.98	0.87	0.85	0.72	0.53	0.55	0.71	0.85	0.9
Other Current Assets	0.99	0.94	0.56	0.94	0.98	0.96	0.23	-0.62	0.92	0.93	0.97	0.97	0.98	0.85	0.9		0.85	0.95	0.9	0.98	0.89	0.74	0.76	0.92	0.93	0.94
Other Stockholder Equity	0.85	0.8	0.84	0.94	0.8	0.88	0.22	-0.39	0.91	0.84	0.88	0.78	0.8	0.53	0.82	0.85		0.89	0.9	0.8	0.63	0.68	0.53	0.7	0.79	0.79
Total Liab	0.95	0.97	0.55	0.92	0.9	0.98	0.41	-0.42	0.89	0.93	0.98	0.88	0.92	0.73	0.98	0.95	0.89		0.92	0.9	0.77	0.63	0.61	0.79	0.89	0.93
Property Plant And Equipment Gross	0.9	0.87	0.65	0.91	0.85	0.94	0.15	-0.44	0.94	0.94	0.92	0.83	0.87	0.62	0.87	0.9	0.9	0.92		0.85	0.72	0.82	0.51	0.76	0.79	0.81
Total Current Assets	0.99	0.9	0.5	0.91	0.99	0.92	0.16	-0.66	0.89	0.91	0.93	1.0	0.98	0.9	0.85	0.98	0.8	0.9	0.85		0.91	0.77	0.83	0.95	0.96	0.93
Short Term Debt	0.88	0.83	0.42	0.78	0.9	0.8	0.27	-0.6	0.75	0.71	0.8	0.91	0.89	0.86	0.72	0.89	0.63	0.77	0.72	0.91		0.65	0.9	0.87	0.78	0.8
Common Stock Total Equity	0.73	0.58	0.57	0.76	0.76	0.66	-0.3	-0.64	0.81	0.77	0.65	0.76	0.76	0.65	0.53	0.74	0.68	0.63	0.82	0.77	0.65		0.54	0.77	0.69	0.58
Short Term Investments	0.76	0.69	0.37	0.64	0.81	0.61	0.23	-0.51	0.6	0.54	0.63	0.86	0.76	0.8	0.55	0.76	0.53	0.61	0.51	0.83	0.9	0.54		0.78	0.77	0.72
Common Stock	0.92	0.77	0.44	0.87	0.96	0.84	-0.01	-0.86	0.84	0.84	0.85	0.94	0.95	0.94	0.71	0.92	0.7	0.79	0.76	0.95	0.87	0.77	0.78		0.9	0.88
Inventory	0.95	0.86	0.43	0.88	0.95	0.88	0.21	-0.61	0.83	0.89	0.91	0.94	0.94	0.86	0.85	0.93	0.79	0.89	0.79	0.96	0.78	0.69	0.77	0.9		0.96
Property Plant Equipment	0.96	0.9	0.41	0.89	0.95	0.94	0.32	-0.58	0.81	0.89	0.96	0.92	0.93	0.82	0.9	0.94	0.79	0.93	0.81	0.93	0.8	0.58	0.72	0.88	0.96

Click cells to compare fundamentals

Vericel Corp Account Relationship Matchups

Vericel Corp fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	153.2M	205.6M	243.7M	273.0M	353.7M	371.3M
Other Current Liab	1.2M	7.7M	41K	16.2M	17.2M	18.1M
Total Current Liabilities	19.8M	22.5M	26.1M	37.5M	45.7M	48.0M
Total Stockholder Equity	111.1M	134.3M	170.5M	192.3M	226.0M	237.2M
Property Plant And Equipment Net	32.2M	57.7M	59.0M	57.4M	115.1M	120.9M
Net Debt	814K	19.6M	(18.2M)	(3.5M)	1.3M	1.3M
Retained Earnings	(378.7M)	(375.8M)	(383.3M)	(400.0M)	(403.2M)	(383.0M)
Accounts Payable	6.3M	6.8M	9.0M	16.9M	22.3M	23.5M
Cash	26.9M	33.6M	68.3M	51.1M	86.9M	91.2M
Non Current Assets Total	41.6M	82.0M	85.2M	86.1M	148.0M	155.4M
Cash And Short Term Investments	69.7M	75.8M	103.4M	119.5M	127.3M	133.7M
Net Receivables	32.2M	34.5M	37.4M	46.5M	58.4M	61.3M
Common Stock Shares Outstanding	44.2M	47.3M	46.5M	47.1M	47.6M	50.0M
Liabilities And Stockholders Equity	153.2M	205.6M	243.7M	273.0M	353.7M	371.3M
Non Current Liabilities Total	22.4M	48.9M	47.2M	43.3M	82.0M	86.1M
Other Current Assets	3.0M	3.9M	4.2M	4.8M	6.9M	7.2M
Other Stockholder Equity	21K	127.6M	177.9M	592.3M	681.1M	715.2M
Total Liab	42.1M	71.3M	73.2M	80.7M	127.7M	134.1M
Property Plant And Equipment Gross	32.2M	30K	59.0M	57.4M	137.3M	144.2M
Total Current Assets	111.7M	123.6M	158.5M	186.9M	205.6M	215.9M
Accumulated Other Comprehensive Income	21K	14K	(154K)	(978K)	(100K)	(105K)
Common Stock Total Equity	489.7M	6.6M	553.9M	593.2M	682.2M	716.3M
Short Term Investments	42.8M	42.2M	35.1M	68.5M	40.5M	42.5M
Common Stock	489.7M	510.1M	553.9M	593.2M	629.2M	660.7M
Inventory	6.8M	9.4M	13.4M	16.0M	13.1M	13.7M
Property Plant Equipment	32.2M	57.7M	59.0M	57.4M	66.0M	69.3M
Net Tangible Assets	111.1M	134.3M	170.5M	184.8M	212.5M	223.1M
Retained Earnings Total Equity	(378.7M)	(375.8M)	(383.3M)	(400.0M)	(360.0M)	(378.0M)
Non Currrent Assets Other	89K	211K	528K	1.3M	771K	732.5K

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Vericel Corp Ord using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:

How To Invest In Vericel

Details

Is Vericel Stock a good investment?

Details

What is Vericel Corp's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

Note that the Vericel Corp Ord information on this page should be used as a complementary analysis to other Vericel Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Vericel Stock analysis

When running Vericel Corp's price analysis, check to measure Vericel Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vericel Corp is operating at the current time. Most of Vericel Corp's value examination focuses on studying past and present price action to predict the probability of Vericel Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vericel Corp's price. Additionally, you may evaluate how the addition of Vericel Corp to your portfolios can decrease your overall portfolio volatility.

	Fundamental Analysis View fundamental data based on most recent published financial statements
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets

Is Vericel Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.045

Earnings Share

0.01

Revenue Per Share

4.349

Quarterly Revenue Growth

0.25

Return On Assets

(0.01)

The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Vericel Depreciation vs Net Income Analysis

Depreciation vs Net Income

Depreciation vs Net Income Correlation Analysis

Correlation Coefficient

Depreciation

Net Income

Vericel Corp fundamental ratios Correlations

Vericel Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Vericel Corp fundamental ratios Accounts

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Vericel Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Stockholder Equity	+ 0.99	Total Assets
Other Current Assets	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity

Common Stock	- 0.86	Retained Earnings
Common Stock Shares Outstanding	- 0.79	Retained Earnings
Net Receivables	- 0.7	Retained Earnings
Retained Earnings	- 0.69	Total Stockholder Equity
Total Current Assets	- 0.66	Retained Earnings
Common Stock Total Equity	- 0.64	Retained Earnings